| Product Name | CAS NO. | Classification | API |
| Oxaliplatin(GMP+CEP) | 61825-94-3 | Anti-tumor | Oxaliplatin |
| Cisplatin | 15663-27-1 | Anti-tumor | Cisplatin |
| Carboplatin | 41575-94-4 | Anti-tumor | Carboplatin |
| Nedaplatin | 95734-82-0 | Anti-tumor | Nedaplatin |
| Diiododiammine Platinum | 15978-93-5 | Anti-tumor | Oxaliplatin |
| Hexachloroplatinum(Ⅳ)Acid Hydrat | 16941-12-1 | Anti-tumor | Oxaliplatin |
| Potassium Hexachloroplatinate(IV) | 16921-30-5 | Anti-tumor | Oxaliplatin |
| Potassium Tetrachloroplatinate(Ⅱ) | 10025-99-7 | Anti-tumor | Oxaliplatin |
| 1,2-Cyclohexanediamine | 694-83-7 | Anti-tumor | Oxaliplatin |
| Trans-1,2-diaminocyclohexane | 1121-22-8 | Anti-tumor | Oxaliplatin |
| (1R,2R)-(-)-1,2- diaminocyclohexane acid | 20439-47-8 | Anti-tumor | Oxaliplatin |
| Capecitabine(GMP+CEP) | 154361-50-9 | Anti-tumor | Capecitabine |
| 1,2,3-triacetyl-5-deoxy-β-D-Ribose | 62211-93-2 | Anti-tumor | Capecitabine |
| Lapatinib | 231277-92-2 | Anti-tumor | Lapatinib |
| Lapatinib Ditosylate Monohydrate | 388082-78-8 | Anti-tumor | Lapatinib |
| Dasatinib Monohydrate | 863127-77-9 | Anti-tumor | Dasatinib |
| 4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide | 417716-92-8 | Anti-tumor | Lenvatinib |
| Mesylate/Osimertinib | 1421373-66-1 | Anti-tumor | Osimertinib |
| Palbociclib | 571190-30-2 | Anti-tumor | Palbociclib |
| 4-(6-Aminopyridin-3-yl)piperazine-1-carboxylic acid tert-butyl ester | 571188-59-5 | Anti-tumor | Palbociclib |
| 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | 1016636-76-2 | Anti-tumor | Palbociclib |
| Lenalidomide | 191732-72-6 | Anti-tumor | Lenalidomide |
| 3-Amino-2,6-piperidinedione hydrochloride | 24666-56-6 | Anti-tumor | Lenalidomide |
| Methyl 2-bromomethyl-3-nitrobenzoate | 98475-07-1 | Anti-tumor | Lenalidomide |
| Bortezomib | 179324-69-7 | Anti-tumor | Bortezomib |
| Enzalutamide | 915087-33-1 | Anti-tumor | Enzalutamide |
| 4-Isothiocyanato-2-(trifluoromethyl)benzonitrile | 143782-23-4 | Anti-tumor | Enzalutamide |
| Pemetrexed Disodium Heptahydrate(CEP) | 357166-29-1 | Anti-tumor | Pemetrexed Disodium |
| Diethyl L-glutamate Hydrochloride | 1118-89-4 | Anti-tumor | Pemetrexed Disodium |
| Pemetrexed Disodium INT-4 | 137281-39-1 | Anti-tumor | Pemetrexed Disodium |
| Zoledronic Acid Hydrate | 165800-06-6 | Anti-tumor | Zoledronic Acid |
| Miriplatin | 141977-79-9 | Anti-tumor | Miriplatin |
| Dicydoplatin | 287402-09-9 | Anti-tumor | Dicydoplatin |
| 1,1-cyclobutanedicarboxylic | 5445-51-2 | Anti-tumor | Carboplatin |
| 2-Aminoethylmethylsulfone Hydrochloride | 104458-24-4 | Anti-tumor | Lapatinib |
| 3-Chloro-4-(3-fluorobenzyloxy)aniline | 202197-26-0 | Anti-tumor | Lapatinib |
| 3-Chloro-4-(3-fluorobenzyloxy)nitrobenzene | 443882-99-3 | Anti-tumor | Lapatinib |
| 4-Chloro-6-iodoquinazoline | 98556-31-1 | Anti-tumor | Lapatinib |
| 5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde | 231278-84-5 | Anti-tumor | Lapatinib |
| 2-Formylfuran-5-boronic Acid | 27329-70-0 | Anti-tumor | Lapatinib |
| 6-Iodoquinazolin-4-one | 16064-08-7 | Anti-tumor | Lapatinib |
| N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine | 231278-20-9 | Anti-tumor | Lapatinib |
| Lapatinib Ditosylate | 388082-77-7 | Anti-tumor | Lapatinib |
| 4-Amino-3-chlorophenol | 17609-80-2 | Anti-tumor | Lenvatinib |
| 4-Amino-3-chlorophenol Hydrochloride | 52671-64-4 | Anti-tumor | Lenvatinib |
| 4-Chloro-7-methoxyquinoline-6-carboxamide | 417721-36-9 | Anti-tumor | Lenvatinib |
| 4-Chloro-7-methoxyquinoline-6-carboxylic acid methyl ester | 205448-66-4 | Anti-tumor | Lenvatinib |
| 1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxylic acid methyl ester | 205448-65-3 | Anti-tumor | Lenvatinib |
| N-(2-Chloro-4-hydroxyphenyl)-N'-cyclopropyl-urea | 796848-79-8 | Anti-tumor | Lenvatinib |
| Lenvatinib Mesylate | 857890-39-2 | Anti-tumor | Lenvatinib |
